Results 41 to 50 of about 17,036,332 (312)
Dagstuhl Reports, Volume 11, Issue 3, April 2021, Complete Issue
Dagstuhl Reports, Volume 11, Issue 3, March 2021, Complete ...
core +1 more source
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
Dagstuhl Reports, Table of Contents, Volume 9, Issue 11, 2019
Dagstuhl Reports, Table of Contents, Volume 9, Issue 11 ...
core +1 more source
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi +9 more
wiley +1 more source
Dagstuhl Reports, Table of Contents, Volume 11, Issue 5, 2021
Dagstuhl Reports, Table of Contents, Volume 11, Issue 5 ...
core +1 more source
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
Dagstuhl Reports, Volume 7, Issue 11, November 2017, Complete Issue
Dagstuhl Reports, Volume 7, Issue 11, November 2017, Complete ...
core +1 more source
Dagstuhl Reports, Volume 11, Issue 1, February 2021, Complete Issue
Dagstuhl Reports, Volume 11, Issue 1, January 2021, Complete ...
core +1 more source
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
Dagstuhl Reports, Table of Contents, Volume 11, Issue 7, 2021
Dagstuhl Reports, Table of Contents, Volume 11, Issue 7 ...
core +1 more source

